Key result
Aortic valve repair for AI carries an ~11% reoperation rate linked to pericardial patch augmentation.
Why the study?
The study was conducted to assess early and late clinical outcomes and investigate predictors of recurrence in patients undergoing aortic valve repair surgery for aortic valve insufficiency.
Cohort (n=151)
No
Aortic valve repair for aortic insufficiency is associated with excellent long-term survival, but the use of autologous pericardial patch augmentation is a significant independent predictor of recurrent severe insufficiency requiring reoperation.
Answers are grounded in this paper and cite their sources.
Caution advised with pericardial patch in aortic valve repair; observational data leaves open optimal techniques for durability.
Objective To assess early and late clinical outcomes in patients who underwent aortic valve repair surgery for aortic valve insufficiency, and to investigate predictors for recurrence. Methods Of 151 consecutive patients who underwent aortic valve repair surgery for varying degrees of aortic insufficiency (AI) in our department between 2004 and 2018, 60 (40%) underwent aortic root replacement, 71 (47%) aortic cusp plication, 31 (20%) subcommissural annuloplasty, 29 (19%) circular annuloplasty, and 28 (18%) autologous pericardial patch augmentation. Results One patient died in the hospital (0.7%). Mean clinical and echocardiographic follow-up was 62±43 months (range 1 to 159) and 50 ± 40 months (range 1 to 158), respectively. The overall survival rate was 99.3% at 1 year and 98% at 5 years of follow-up. Seventeen patients (11.3%) had recurrent severe AI, and all of them underwent reoperation with a mean duration to reoperation of 35 ± 39 months. Risk factors for the development of recurrent significant AI (≥3) or reoperation, by univariable analysis, were unicuspid or bicuspid aortic valve (AV) ( P = 0.018), the use of subcommissural annuloplasty ( P = 0.010), the need for cusp repair ( P = 0.001), and the use of pericardial patch augmentation ( P < 0.001). By multivariable analysis only the use of pericardial patch augmentation emerged as a significant independent predictor for the development of recurrent significant AI (≥3) or reoperation ( P = 0.020). Conclusion AV repair can be performed with low morbidity and mortality, with good early and late clinical outcomes. However, in our experience there was a significant rate of recurrent AI especially in patients who underwent cusp augmentation using glutaraldehyde-treated autologous pericardial patch.
No takes yet. Share an insight, caveat, or question.
Ram et al. (2019) conducted a cohort in Aortic valve insufficiency (n=151). Aortic valve repair surgery was evaluated on Recurrent significant AI (≥3) or reoperation. Aortic valve repair for aortic insufficiency yielded 98% 5-year survival, but 11.3% required reoperation for recurrent severe AI, with pericardial patch augmentation as an independent predictor.
Synapse has enriched 10 related papers. Consider them for comparative context: